Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 12 , ISSUE 2 ( April-June, 2023 ) > List of Articles

CASE REPORT

An Unusual Case of Thoracic Empyema Secondary to Streptococcus anginosus: A Case Report

Jithin K Sreedharan, Yasmeen F Mirza, Saad M AlRabeeah, Abdullah S Alqahtani, Jaber S Alqahtani, Meshal Alenezi, Siju K George, Mohammed Regal

Keywords : Bronchopleural fistula, Empyema, Parapneumonic effusion, Streptococcus anginosus

Citation Information : Sreedharan JK, Mirza YF, AlRabeeah SM, Alqahtani AS, Alqahtani JS, Alenezi M, George SK, Regal M. An Unusual Case of Thoracic Empyema Secondary to Streptococcus anginosus: A Case Report. Indian J Respir Care 2023; 12 (2):178-181.

DOI: 10.5005/jp-journals-11010-1036

License: CC BY-NC-SA 4.0

Published Online: 30-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Few incidences of adult patients with rapidly progressing empyema complicated by bronchopleural fistula related to Streptococcus anginosus have been documented. A 53-year-old male with a history of smoking 20 packs/year. He was admitted with 5 days history of worsening cough, respiratory distress, fever, headache, and pleuritic chest pain. Thoracic ultrasound was done, showing septated right-sided pleural effusion, confirming empyema. After decortication, pus culture showed heavy growth of Streptococcus anginosus. The drug susceptibility test revealed susceptibility to penicillin, erythromycin, cephalosporin, and piperacillin/tazobactam. The patient was successfully treated with piperacillin/tazobactam and early open thoracotomy decortication surgery was performed and discharged within 11 days. Although the number of empyema cases infected with Streptococcus anginosus is low, patients should be managed early depending on accurate diagnosis using the right antibiotics, optimal drainage, and surgical intervention if necessary. Further knowledge and research on the clinical presentation and the pathogenesis of thoracic Streptococcus anginosus are needed to have better clinical outcomes in future cases. The specific classification of empyema is suggested using lung ultrasound for the best management options.


PDF Share
  1. Carroll KC, Pfaller MA, Landry ML, et al., editors. Manual of Clinical Microbiology [Internet]. 12th ed. American Society of Microbiology; 2019. Available from: http://www.asmscience.org/content/book/10.1128/9781555819842
  2. Murray PR, Rosenthal KS, Pfaller MA. Medical microbiology E-book. Elsevier Health Sciences; 2020.
  3. Madrid-Carbajal CJ, Molinos L, García-Clemente M, et al. Descripción de casos de derrame pleural secundario a Streptococcus milleri. Arch Bronconeumol 2014;50(9):404–406. DOI: 10.1016/j.arbres.2013.11.026
  4. Shebl E, Paul M. Parapneumonic Pleural Effusions And Empyema Thoracis. Treasure Island (FL); 2021.
  5. Yu H. Management of pleural effusion, empyema, and lung abscess. Semin Intervent Radiol 2011;28(1):75–86. DOI: 10.1055/s-0031-1273942
  6. Ravikanth R, Mathew S, Pinto DS. Management of acquired bronchopleural fistula due to chemical pneumonia. Ci Ji Yi Xue Za Zhi 2018;30(2):116–118. DOI: 10.4103/tcmj.tcmj_98_17
  7. Wong CA, Donald F, Macfarlane JT. Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients. Thorax 1995;50(10):1093–1096. DOI: 10.1136/thx.50.10.1093
  8. Hocken DB, Dussek JE. Streptococcus milleri as a cause of pleural empyema. Thorax 1985;40(8):626–628. DOI: 10.1136/thx.40.8.626
  9. Friedrichs C, Rajkumari R, Itzek A, et al. Contribution of streptococcus anginosus to infections caused by groups C and G Streptococci, Southern India. Emerg Infect Dis 2010;16(4):656–663. DOI: 10.3201/eid1604.090448
  10. Pilarczyk-Zurek M, Sitkiewicz I, Koziel J. The clinical view on Streptococcus anginosus group–opportunistic pathogens coming out of hiding. Front Microbiol 2022;13:956677. DOI: 10.3389/fmicb.2022.956677
  11. Kuryłek A, Stasiak M, Kern-Zdanowicz I. Virulence factors of Streptococcus anginosus–a molecular perspective. Front Microbiol 2022;13:1025136. DOI: 10.3389/fmicb.2022.1025136
  12. Noguchi S, Yatera K, Kawanami T, et al. The clinical features of respiratory infections caused by the Streptococcus anginosus group. BMC Pulm Med 2015;15:133. DOI: 10.1186/s12890-015-0128-6
  13. Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis 2007;45(11):1480–1486. DOI: 10.1086/522996
  14. Gupta A, Dutt N, Patel N. The different treatment modalities of pyopneumothorax- study of 50 cases. Int J Med Sci Public Heal 2013;3(1):609. DOI: 10.5455/ijmsph.2013.180420132
  15. Che Rahim MJ, Mohammad N, Wan Ghazali WS. Pyopneumothorax secondary to Streptococcus milleri infection. BMJ Case Rep 2016;2016:bcr2016217537. DOI: 10.1136/bcr-2016-217537
  16. Eller P, Theurl I, Koppelstaetter F, et al. Pyopneumothorax due to Streptococcus milleri. Wien Klin Wochenschr 2006;118(7–8):207. DOI: 10.1007/s00508-006-0558-5
  17. Zhang Z, Xiao B, Liang Z. Successful treatment of pyopneumothorax secondary to Streptococcus constellatus infection with linezolid: a case report and review of the literature. J Med Case Rep 2020;14(1):180. DOI: 10.1186/s13256-020-02475-w
  18. Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tob Induc Dis 2020;18:60. DOI: 10.18332/tid/123845
  19. Patel KM, Ullah K, Patail H, et al. Ultrasound for pleural disease. Beyond a pocket of pleural fluid. Ann Am Thorac Soc 2021;18(5):749–756. DOI: 10.1513/AnnalsATS.202008-948CME
  20. Said AM, Samra SR, Al Fakharny KM, et al. Sonographic findings of thoracic empyema: outcome perspectives. Egypt J Bronchol 2022;16(1):36. DOI: 10.1186/s43168-022-00140-y
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.